// App-Quantinova.ai

[THU0083] : NON-ADHERENCE TO DMARDS WILL SIGNIFICANTLY INFLUENCE THE FIRST-YEAR OUTCOME OF RHEUMATOID ARTHRITIS

Researchers

Presenter

  • A. Pasma

Principal Investigators

  • L. Schenk

  • R. Timman

  • J.J. Busschbach

  • B. van den Bemt

  • E. Molenaar

  • W. Noort-van der Laan

  • S. Schrauwen

  • A. van-t Spijker

  • J.M. Hazes

Medical Centers

  • Department of Clinical Chemistry, Sint Franciscus Gasthuis, Rotterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Inflammatory Arthritis

  • Rheumatoid arthritis

  • Depression

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved